Multiple Manufacturers

AFINITOR

Manufacturer:

Multiple Manufacturers

Afinitor HCPCS:

J7527

HCPCS Code Descriptor:

Everolimus, oral, 0.25 mg

Category:

J Code

Afinitor NDCs:

00054-0471-21, 00078-0414-20, 49884-0283-02, 00054-0472-21, 49884-0160-02, 00078-0415-20, 00054-0604-21, 00078-0422-20, 67877-0721-31, 00054-0497-14, 00054-0480-13, 00054-0480-14, 00054-0497-13, 00054-0481-13, 00054-0481-14, 00078-0626-51, 00078-0594-51, 00078-0627-51, 00078-0620-51, 00078-0567-51, 00078-0628-51, 00078-0566-51, 00078-0417-61, 70377-0011-11, 00078-0414-61, 00078-0415-61, 00078-0422-61, 67877-0719-31, 49884-0158-02, 67877-0718-31, 00054-0470-21, 00078-0417-20, 00078-0626-61, 00078-0594-61, 00078-0627-61, 00078-0628-61, 00078-0567-61, 00078-0620-61, 00078-0566-61, 67877-0720-31, 49884-0159-02

Primary Type:

Oncology

Generic/Specialty Status:

Multi-Source

Package Type:

Not Found

Route of Administration:

Oral

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

00054-0497-14, 00054-0480-14, 00054-0481-14

About Afinitor:

AFINITOR is a medication manufactured by multiple manufacturers and aligned to the J Code: J7527. AFINITOR is administered via the oral route of administration.

ACCESS PRICING AND MORE BY REGISTERING

J7527 Added Date:

January 1, 2013

J7527 Effective Date:

January 1, 2014

J7527 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Afinitor billing and coding information.
Afinitor patient assistance information can be found through Novartis Patient Support at the URL: https://www.novartis.us/our-products/patient-assistance/patient-assistance-foundation-enrollment
AFINITOR prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date.
Our team has not yet identified a source of side effects information for AFINITOR. Please check back in a few weeks.